Search all trials

Find therapies in clinical trials near you – page 4

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hormone-refractory prostate cancer

Recruiting

Registered drugNo placebo

Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drug

Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Mrna-4157

Contact Research Centre

Pulmonary embolism+7

Recruiting

Registered drug

Study on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Rosuvastatin Calcium

Contact Research Centre

IgA nephropathy

Recruiting

Registered drugNo placebo

Long-Term Safety Study of Iptacopan for Adults with IgA Nephropathy After Completing a Previous Study, Including ACE Inhibitors and ARBs Drug Combination

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Iptacopan

Contact Research Centre

Neoplasm

Recruiting

InvestigationalNo placebo

Study of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Patritumab Deruxtecan

Contact Research Centre

Plasma cell myeloma refractory

Recruiting

Registered drugNo placebo

Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Pulmonary sarcoidosis

Recruiting

Investigational

Study on the Effects of OATD-01 for Patients with Active Pulmonary Sarcoidosis

Investigational

Norway

Participants:18–64 years
Substances:5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-Methylmorpholino)Piperidin-1-Yl)-1H- 1,2,4-Triazol-3-Amine

Contact Research Centre

Chronic lymphocytic leukaemia+1

Recruiting

Registered drugNo placebo

Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Crohn's disease

Recruiting

Investigational

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Colitis ulcerative+2

Recruiting

InvestigationalNo placebo

Study on the Long-term Safety of Guselkumab for Children with Crohn's Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis

InvestigationalNo placebo

Norway

Participants:0–17 years · 18–64 years
Substances:Guselkumab

Contact Research Centre

Adenocarcinoma of colon

Recruiting

Registered drugNo placebo

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Metastatic malignant melanoma

Recruiting

InvestigationalNo placebo

Study Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma

InvestigationalNo placebo

Norway

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Find therapies in clinical trials near you – page 4

120 trials match your criteria

Hormone-refractory prostate cancer

Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

Non-small cell lung cancer

Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

Pulmonary embolism+7

Study on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism

IgA nephropathy

Long-Term Safety Study of Iptacopan for Adults with IgA Nephropathy After Completing a Previous Study, Including ACE Inhibitors and ARBs Drug Combination

Neoplasm

Study of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors

Plasma cell myeloma refractory

Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

Pulmonary sarcoidosis

Study on the Effects of OATD-01 for Patients with Active Pulmonary Sarcoidosis

Chronic lymphocytic leukaemia+1

Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Crohn's disease

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Colitis ulcerative+2

Study on the Long-term Safety of Guselkumab for Children with Crohn's Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis

Adenocarcinoma of colon

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Metastatic malignant melanoma

Study Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.